PFIZER LTD. - 500680 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201515-12-2023
PFIZER LTD. - 500680 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015PFIZER LTD. - 500680 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Pfizer shares sink after it resets 2024 COVID expectations
Revenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a further drop from the $13 billion analysts' forecast and Pfizer's own lowered view of $12.5 billion for this year.PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, we enclose herewith copies of newspaper advertisement of the Postal Ballot Notice published on December 8, 2023 in Business Standard (English) and Sakaal (Marathi). Request you to take the above on record.PFIZER LTD. - 500680 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, please find enclosed Notice of the Postal Ballot along with explanatory statement for seeking the approval of the Members of the Company for appointment of Mr. P. Rengan (DIN: 10362899) as a Whole-time Director of the Company designated as Executive Director - Plant Operations for a period of 5 years with effect from October 28, 2023.PFIZER LTD. - 500680 - Pfizer Limited - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pfizer Limited - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Retirement
Pursuant to Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015, the Company hereby informs that Mr. Milind Patil, Chief Financial Officer of the Company has retired from the services of the Company effective close of business on November 30, 2023. Consequently, Mr. Patil also ceased to be a Senior Management Personnel effective the said date.PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation regarding appointment of Senior Management Personnel of the CompanyPFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Resignation of Director
The Company hereby wishes to notify that Mr. Milind Patil has resigned as a Director on the Board of Directors of the Company with effect from close of business on November 13, 2023, consequent to the expiry of his 5 year term as Executive Director - Finance effective the said date and his ensuing retirement from the services of the Company effective November 30, 2023. Request you to please take the same on record.PFIZER LTD. - 500680 - Additional Details Requested For Corporate Announcement Filed On November 1, 2023 Under Regulation 30 Of SEBI (LODR) Regulations, 2015
This is in reference to the captioned Announce made by the Company on November 1, 2023 and BSE''s email date November 2, 2023 requesting additional details on the same.